This inventor holds 3 USPTO granted patents. Top assignees: Harvard College, The Brigham and Women's Hospital, Inc.. Active years: 1987-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1987-1998
Title: Inventor Heinz G. Remold: Pioneer in Vasodilatory and Immune Suppressing Peptides
Introduction
Heinz G. Remold, an innovative inventor based in Brookline, MA, has made significant contributions to the field of biomedical research. With a total of three patents to his name, Remold has focused his research on the development of unique proteins derived from the sand fly species, Lutzomyia longipalpis, which hold promise for therapeutic applications in vasodilation and immune suppression.
Latest Patents
Remold's recent patents include groundbreaking work on vasodilatory and immune suppressant peptides. Specifically, his patented proteins derived from Lutzomyia longipalpis are capable of inducing vasodilation in mammals. The patents disclose detailed data characterizing these proteins and the nucleic acids that encode them. Additionally, he describes a method for temporarily inactivating the immune system in mammals through the administration of the Lutzomyia protein, CGRP, calcitonin, or their active immune-suppressing analogs. This pioneering research opens new avenues for medical therapies targeting vascular and immune system disorders.
Career Highlights
Throughout his career, Heinz G. Remold has held prominent positions that enhance his research capabilities. He has worked with prestigious institutions, including Harvard University and Brigham and Women's Hospital, Inc. His involvement with such esteemed organizations underscores his status as a leading figure in his field.
Collaborations
Remold’s success is also attributable to his collaborations with other notable researchers. He has worked alongside eminent colleagues such as Jose M. Ribeiro and Ethan A. Lerner. These collaborations have allowed for a rich exchange of ideas and expertise, further advancing the field of peptide research and its potential applications in medicine.
Conclusion
Heinz G. Remold's contributions to the field of biomedical innovation, particularly in the areas of vasodilatory and immune suppressing peptides, underscore his status as a notable inventor. With a strong academic background and collaborative efforts, he continues to push the boundaries of what is possible in medical science, paving the way for future advancements in therapeutic treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

